Regional Chemotherapy Is a Valuable Second-Line Approach in Metastatic Esophageal Cancer after Failure to First-Line Palliative Treatment

Regional Chemotherapy Is a Valuable Second-Line Approach in Metastatic Esophageal Cancer after Failure to First-Line Palliative Treatment

Background: Therapeutic options in metastatic esophageal cancer (EC) are limited with unsatisfactory results. We evaluated the efficacy of regional chemotherapy (RegCTx) approach in diffuse metastatic EC using arterial infusion (AI), upper abdominal perfusion (UAP) and isolated-thoracic perfusion (I...

Full description

Bibliographic Details
Main Authors:	Yogesh Vashist, Kornelia Aigner, Miriam Dam, Sabine Gailhofer, Karl R. Aigner
Format:	Article
Language:	English
Published:	MDPI AG 2022-07-01
Series:	Current Oncology
Subjects:	esophageal cancer survival second-line therapy regional chemotherapy isolated thoracic perfusion arterial infusion
Online Access:	https://www.mdpi.com/1718-7729/29/7/386

Similar Items

Carotid artery infusion via implantable catheters for squamous cell carcinoma of the tonsils
by: Karl Reinhard Aigner, et al.
Published: (2018-06-01)

Atypical Esophageal Metastasis in the Thoracic Wall
by: Sofia R. Lopes, et al.
Published: (2024-07-01)

Transarterial infusion chemotherapy for advanced esophageal cancer with airway stenosis
by: Gang Zhou, et al.
Published: (2023-08-01)

Recurrent chylothorax as a consequence of esophageal stent
by: Daisy Young, et al.
Published: (2023-01-01)

Severe esophageal stenosis in a patient with metastatic colon cancer following palliative radiotherapy, ramucirumab, and chemotherapy
by: Keiko Akahane, et al.
Published: (2020-05-01)

Results of combined and chemoradiation treatment of patients with thoracic esophageal cancer according to the data of the regional cancer center
by: E. A. Toneev, et al.
Published: (2023-11-01)

Characteristics of Patients With Esophageal Dysphagia Assessed by Chest X-Ray Imaging After Videofluoroscopic Swallowing Study
by: Young-Kee Min, et al.
Published: (2020-02-01)

Delayed diagnosis of thoracic esophageal rupture due to blunt abdominal trauma without chest trauma: A case report
by: Jae Jun Kim, et al.
Published: (2022-09-01)

Efficacy and safety of camrelizumab combined with chemotherapy as second-line treatment for locally advanced, recurrent, or metastatic esophageal squamous cell carcinoma
by: Yinfang Gu, et al.
Published: (2025-02-01)

Esophageal lung resection and prosthesis placement in a preterm neonate
by: Lalit Parida, et al.
Published: (2015-01-01)

Pattern of Lymphatic Metastasis and In fluencing Factors in Thoracic Esophageal Carcinoma
by: Jun WANG, et al.
Published: (2009-10-01)

Neglected Esophageal Injury Presenting With Spontaneously Shrunken Retroesophageal Pocket
by: Chin-Chih Chang, et al.
Published: (2008-09-01)

Cost-Effectiveness Analysis of Tislelizumab Plus Chemotherapy as First-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma in China
by: Zhou C, et al.
Published: (2023-11-01)

pTEVAR of an aorto-esophageal fistula in esophageal cancer: Case report and review of the literature
by: Andreas D. Owczarek, MD, et al.
Published: (2023-07-01)

Economic evaluation of tislelizumab versus chemotherapy as second-line treatment for advanced or metastatic esophageal squamous cell carcinoma in China
by: Fenghao Shi, et al.
Published: (2022-11-01)

Cost‐effectiveness analysis of pembrolizumab plus chemotherapy versus chemotherapy as the first‐line treatment for advanced esophageal cancer
by: Zhuo‐Miao Ye, et al.
Published: (2023-03-01)

Robotic esophagectomy with function‐preserving radical mediastinal lymphadenectomy for esophageal cancer
by: Raja Kalayarasan, et al.
Published: (2025-01-01)

Safety and tolerability of first‐line durvalumab with tremelimumab and chemotherapy in esophageal squamous cell carcinoma
by: Dae Ho Lee, et al.
Published: (2023-08-01)

European Society of Organ Transplantation (ESOT) Consensus Statement on Machine Perfusion in Cardiothoracic Transplant
by: Cristiano Amarelli, et al.
Published: (2024-11-01)

Cost-effectiveness analysis of pembrolizumab vs. chemotherapy as second-line treatment for advanced esophageal carcinoma in the United States
by: Jia Hu, et al.
Published: (2022-12-01)

Role of palliative chemotherapy and targeted therapy in advanced esophageal and gastroesophageal junction cancers
by: Vijai Simha, et al.
Published: (2019-01-01)

Unusual Presentation of a Metastatic Esophageal Carcinoma
by: Katarzyna Orlicka, et al.
Published: (2012-05-01)

Video-Assisted Thoracic Surgery vs. Thoracotomy for the Treatment in Patients With Esophageal Leiomyoma: A Systematic Review and Meta-Analysis
by: Cheng Shen, et al.
Published: (2022-01-01)

First-line sintilimab plus chemotherapy in locally advanced or metastatic esophageal squamous cell carcinoma: A cost-effectiveness analysis from China
by: Jian Shen, et al.
Published: (2022-12-01)

Esophageal foreign body removal under holmium laser-assisted gastroscope: A case report
by: Zhe Yang, et al.
Published: (2023-01-01)

Development and Evaluation of a Flexible PVDF-Based Balloon Sensor for Detecting Mechanical Forces at Key Esophageal Nodes in Esophageal Motility Disorders
by: Peng Ran, et al.
Published: (2023-08-01)

Hyperspectral Imaging—A Novel Tool to Assess Tissue Perfusion and Oxygenation in Esophageal Anastomoses
by: Vaz Pimentel Vaz Pimentel, et al.
Published: (2023-01-01)

Cost-Effectiveness Analysis of Sintilimab Combined with Chemotherapy Versus Chemotherapy Alone as the First-Line Treatment for Advanced Esophageal Cancer
by: Zhuo-Miao Ye, et al.
Published: (2022-11-01)

Perfusion index as an early predictor of hypotension during advanced oncothoracic operations (pilot study)
by: L. A. Zimina, et al.
Published: (2024-10-01)

Recommendation for the definition of postoperative radiotherapy target volume based on a pooled analysis of patterns of failure after radical surgery among patients with thoracic esophageal squamous cell carcinoma
by: Xiaofei Zhang, et al.
Published: (2018-12-01)

Early prediction of response to palliative chemotherapy in patients with stage-IV gastric and esophageal cancer
by: Xiaoyuan Ma, et al.
Published: (2023-09-01)

Delayed chylopericardium after radical surgery for esophageal cancer: a case report
by: Pengjie Yang, et al.
Published: (2023-07-01)

Tracheo-esophageal fistula: Successful palliation after failed esophageal stent
by: Rakesh K Chawla, et al.
Published: (2012-01-01)

Efficacy and safety of immunochemotherapy, immunotherapy, chemotherapy, and targeted therapy as first-line treatment for advanced and metastatic esophageal cancer: a systematic review and network meta-analysisResearch in context
by: Zhen Gao, et al.
Published: (2023-09-01)

Innovative regression model-based decision support tool for optimizing radiotherapy techniques in thoracic esophageal cancer
by: Yuxing Li, et al.
Published: (2024-07-01)

Editorial: Chemotherapy in esophageal cancer
by: Jiang Chen, et al.
Published: (2022-12-01)

A rare case of posttraumatic aortic rupture, treated with an endovascular stent graft implantation and complicated with esophageal rupture
by: Dimitar Kyuchukov, et al.
Published: (2022-08-01)

Intralesional steroid infusion using a spray tube to prevent stenosis after endoscopic submucosal dissection of esophageal cancer
by: Atsushi Goto, et al.
Published: (2022-07-01)

The Esophageal Microbiota in Esophageal Health and Disease
by: Erica Bonazzi, et al.
Published: (2024-11-01)

Esophageal Metastatic Adenocarcinoma Diagnosed with Endoscopic Ultrasound
by: Guo Xiang Jonathan Teh, et al.
Published: (2017-11-01)